Koh‐ichi Wada - Concepedia

Author

Koh‐ichi Wada

Drug Discovery Laboratory (Norway)

Also Known As

K Wada, K. Wada, Koh-Ichi Wada, Koh-ichi WADA, Koh-ichi Wada, Kohichi Wada, Koh‐ichi Wada

Publications

846

Citations

H-Index

Concepts

All Affiliations

Drug Discovery Laboratory (Norway)Yamaha (Japan)Yamanashi Research Institute

About

Koh‐ichi Wada is an author at Drug Discovery Laboratory (Norway) specializing in physiology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	492
2	Health Sciences	2	2	40
3	Natural Sciences	2	2	58
4	Anesthesia	2	2	87
5	Biochemistry	2	2	58

Koh‐ichi Wada

Publications

778

Citations

H-Index

Page 1

	Year	Citations
Pharmacological Profile of YM087, A Novel Potent Nonpeptide Vasopressin V1A and V2 Receptor Antagonist, in Vitro and in Vivo Atsuo Tahara, Yuichi Tomura, Koh‐ichi Wada, Journal of Pharmacology and Experimental Therapeutics	1997	139
Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs Takeyuki Yatsu, Yuichi Tomura, Atsuo Tahara, European Journal of Pharmacology NeuropeptidesMedicinePhysiologyNeuropeptide ReceptorNeuropharmacology	1997	77
Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure Takeyuki Yatsu, Yuichi Tomura, Atsuo Tahara, European Journal of Pharmacology Conivaptan HydrochlorideHeart FailureCardiovascular DiseaseMedicinePhysiology	1999	74
Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte Atsuo Tahara, Yuichi Tomura, Koh‐ichi Wada, Cardiovascular Research	1998	71
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells Atsuo Tahara, Masayuki Saito, Toru Sugimoto, British Journal of Pharmacology Pharmacological CharacterizationImmunologyCellular PhysiologyGastrointestinal Peptide HormoneMolecular Pharmacology	1998	63
Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist Atsuo Tahara, Masayuki Saito, Toru Sugimoto, Naunyn-Schmiedeberg s Archives of Pharmacology NeuropeptidesPharmacological CharacterizationMedicinePhysiologyNeuropeptide Receptor	1997	51
Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells Atsuo Tahara, Junko Tsukada, Yuichi Tomura, British Journal of Pharmacology GynecologyCytoskeletonExperimental PharmacologyCellular PhysiologyPharmacologic Characterization	2000	47
Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure Koh‐ichi Wada, Akira Fujimori, Utane Matsukawa, European Journal of Pharmacology Conivaptan HydrochlorideHeart FailureIntravenous AdministrationCardiovascular DiseaseMedicine	2005	35
Effect of YM087, a Potent Nonpeptide Vasopressin Antagonist, on Vasopressin-Induced Hyperplasia and Hypertrophy of Cultured Vascular Smooth-Muscle Cells Atsuo Tahara, Yuichi Tomura, Koh‐ichi Wada, Journal of Cardiovascular Pharmacology	1997	34
Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction Koh‐ichi Wada, Atsuo Tahara, Yukinori Arai, European Journal of Pharmacology HypertensionHeart FailureCardiovascular DiseaseMedicinePhysiology	2002	29

Page 1